|
Sales Soar for Morning-After "Plan B" Pill
Source: Washington Post
NEW YORK -- In the time since it was approved for over-the-counter sales, the morning-after pill has become a huge commercial success for its manufacturer, but its popularity and solid safety record haven't deterred critics from seeking to overturn the milestone ruling.
The pill, marketed by Barr Pharmaceuticals Inc. as Plan B, was the focus of bitter debate for three years. After repeated delays, the Food and Drug Administration declared on Aug. 24, 2006 that customers 18 and older should be able to buy it in pharmacies without a prescription.
Barr began distributing the over-the-counter version last November, and all national pharmacy chains now stock it. The company projects that sales of Plan B will total about $80 million for 2007, almost double the total for 2006 and up eightfold from 2004, when Barr acquired the product as a prescription-only drug.
"Overall, we've been very pleased with the acceptance," said Barr spokeswoman Carol Cox. "The product may not be for everyone but if you find yourself in a position to need it, absolutely it should be available."
The Morning After Pill - Love It or Hate It?
|